- Global Pharma News & Resources

Global Blood Banking and Blood Products Market Analysis Report 2022: Market to Reach $59.5 Billion by 2027 - Blood Plasma Demand Exceeds Supply, Self-Sufficiency is the New Mantra -

DUBLIN--(BUSINESS WIRE)--The "Blood Banking and Blood Products: Global Strategic Business Report" report has been added to's offering.

Global Blood Banking and Blood Products Market to Reach $59.5 Billion by 2027

The global market for Blood Banking and Blood Products estimated at US$45 Billion in the year 2020, is projected to reach a revised size of US$59.5 Billion by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027.

Blood Components & Plasma Products, one of the segments analyzed in the report, is projected to record 4.3% CAGR and reach US$48.4 Billion by the end of the analysis period.

After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Equipment, Blood Tests & Other Consumables segment is readjusted to a revised 3.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $12.3 Billion, While China is Forecast to Grow at 7.1% CAGR

The Blood Banking and Blood Products market in the U.S. is estimated at US$12.3 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$12.2 Billion by the year 2027 trailing a CAGR of 7.1% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 3.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

What`s New?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Key Topics Covered:


  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
  • Recent Market Activity
  • Safety and Availability: The Core Issues
  • Current and Future Analysis
  • World Blood Components and Plasma Market Analysis
  • Red Blood Cells - A Key Blood Component
  • Blood Banking and Blood Products - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)


  • AABB
  • Abbott Laboratories
  • American Red Cross
  • America's Blood Centers
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Beijing Tiantan Biological Products Co., Ltd.
  • Bharat Serums and Vaccines Ltd.
  • Bio Products Laboratory Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Biotest AG
  • Canadian Blood Services
  • Cerus Corporation
  • China Biologic Products, Inc.
  • CSL Behring LLC
  • Fenwal Inc.
  • Fresenius Kabi AG
  • Grifols S.A.
  • Haemonetics Corporation
  • Immucor Inc.
  • Kawasumi Laboratories, Inc.
  • Kedrion S.p.A.
  • LFB Group
  • MacoPharma SA
  • New York Blood Center
  • Octapharma AG
  • Ortho-Clinical Diagnostics, Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Shire plc
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • Terumo BCT Inc.


  • Blood Plasma Demand Exceeds Supply: Self-Sufficiency is the New Mantra
  • Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg Therapy
  • Higher Plasma Center Numbers Key to Secure Raw Material Supply, Costs Remain A Bottleneck
  • Platelet Rich Plasma Therapy Market Scales New Heights
  • Evolution in Plasma Collection Technologies - Current Achievements and Way Ahead
  • Demand for Plasma Derivatives on the Rise
  • Immunoglobulins to See Steady Growth
  • Increasing Awareness of PID and CIPD Disorders to Drive IVIg Market
  • Indications Addressed by Major Global IVIg Manufacturers
  • Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg Therapy
  • New Indications to Drive Demand for Albumin
  • Low Awareness Affects Apha1 Market
  • Recombinants Lead FVIII Market
  • Rising Incidence of Cancer Drives Demand for Apheresis Systems
  • PrIME: An Innovative High-Yield Process to Address Supply Dearth
  • Present State of Plasma Fractionating Industry
  • Plasma Fractionation Industry Concentrated in Developed Countries
  • PrIME Tackles the Issue of Currently Unprocessable Plasma
  • Industry Grappling with Blood Safety & Availability Issues
  • New Infections - A Continuous Threat
  • Synthetic Substitutes to Bridge Demand-Supply Gap in Blood
  • Autologous Transfusion Gearing up for High Growth
  • Out-of-Hospital Transfusions: An Emerging Phenomenon
  • Automation Tapping into Blood Market
  • Automation in Pre-Transfusion Diagnostics
  • Penetration of Automated Equipment in the Plasma Market
  • The Red Blood Cell Collection Opportunity
  • Robots in Blood Banking
  • Blood Banks Switching from Manual to Automated Cooler Validation
  • Automated Systems in Cancer
  • Automated Blood Processing Systems in Open Heart Surgeries
  • Cerus' INTERCEPT Blood System Set to See Wider Adoption
  • Pooling: Economical HIV Testing
  • Ballooning Global Geriatric Populace to Drive Demand for Blood Products
  • Improving Healthcare Expenditure to Foster Growth of Blood Banking Sector

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 07-Feb-2023